31. Consolidated companies as of 31 December 2017
Name of the subsidiary |
Country |
% voting right Galapagos NV (directly or indirectly through subsidiaries) |
Change in % voting right previous period (2017 vs 2016) |
BioFocus DPI AG in liquidation |
Switzerland |
100% |
|
Discovery Partners International GmbH |
Germany |
0% |
(100%) |
Fidelta d.o.o. |
Croatia |
100% |
|
Galapagos Biotech Ltd. (formerly Inpharmatica Ltd.) |
United Kingdom |
100% |
|
Galapagos BV |
The Netherlands |
100% |
|
Galapagos GmbH |
Switzerland |
100% |
100% |
Galapagos NV |
Belgium |
Parent company |
|
Galapagos SASU |
France |
100% |
|
Galapagos, Inc. (formerly BioFocus, Inc.) |
United States |
100% |
|
Xenometrix, Inc. |
United States |
100% |
|
Our German subsidiary, Discovery Partners International GmbH, was liquidated in 2017. In the fourth quarter of 2017 we incorporated a new legal entity in Basel, Switzerland: Galapagos GmbH.
There are no significant restrictions on the group’s ability to access or use assets, or settle liabilities, of one of the group’s subsidiaries.